Table 1.
Baseline characteristics of women diagnosed with COVID-19 in the RCGP RSC database (from 1 January to 21 June 2020) presented by those on HRT, COCP, or neither drug
| Total (N = 5,451) | Neither drug (N = 5,045) | HRT (N = 235) | COCP (N = 171) | |
|---|---|---|---|---|
| Sociodemographic | ||||
| Age (years)a | 59.0 (21.7) | 60.2 (21.7) | 54.6 (9.4) | 29.3 (7.4) |
| Ethnicity recorded | 4,356 (79.9) | 4,024 (79.8) | 193 (82.1) | 139 (81.3) |
| White | 3,534 (64.8) | 3,231 (64.0) | 179 (76.2) | 124(72.5) |
| Asian | 510 (9.4) | 497 (9.9) | 6 (2.6) | 7 (4.1) |
| Black | 211 (3.9) | 203 (4.0) | 4 (1.7) | 4 (2.3) |
| Mixed and other | 101 (1.9) | 93 (1.8) | 4 (1.7) | 4 (2.3) |
| IMD quintile recorded | 5,326 (97.7) | 4,931 (97.7) | 232 (98.7) | 163 (95.3) |
| 5 (least deprived) | 1,136 (20.8) | 1,018 (20.2) | 74 (31.5) | 44 (25.7) |
| 4 | 1,088 (20.0) | 999 (19.8) | 58 (24.7) | 31 (18.1) |
| 3 | 1,054 (19.3) | 986 (19.5) | 36 (15.3) | 32 (18.7) |
| 1 and 2 (most deprived) | 2,048 (37.6) | 1,928 (38.2) | 64 (27.2) | 56 (32.7) |
| Settlement or population density | 5,328 (97.7) | 4,933 (97.8) | 232 (98.7) | 163 (95.3) |
| Rural | 933 (17.1) | 833 (16.5) | 65 (27.7) | 35 (20.5) |
| Urban | 4,395 (80.6) | 4,100 (81.3) | 167 (71.1) | 128 (74.9) |
| Clinical | ||||
| BMI recorded | 5,122 (94.0) | 4,724 (93.6) | 231 (98.3) | 167 (97.7) |
| BMI (kg/m2) | 28.2 (7.3) | 28.3 (7.3) | 29.3 (6.4) | 24.55 (4.5) |
| Smoking status recorded | 5,328 (97.7) | 4,928 (97.7) | 233 (99.1) | 167 (97.7) |
| Non-smoker | 2,128 (39.0) | 1,969 (39.0) | 67 (28.5) | 92 (53.8) |
| Active-smoker | 486 (8.9) | 447 (8.9) | 28 (11.9) | 11 (6.4) |
| Ex-smoker | 2,714 (49.8) | 2,512 (49.8) | 138 (58.7) | 64 (37.4) |
| Co-morbiditya | 3,001 (55.1) | 2,859 (56.7) | 116 (49.4) | 26 (15.2) |
| All medicationsb | 2,452 (45.0) | 2,333 (46.2) | 100 (42.6) | 19 (11.1) |
Includes hypertension, coronary heart disease, diabetes (type 1 or type 2), chronic kidney disease stage 3–5, asthma, COPD, immunocompromised.
Includes antihypertensive medication, lipid-lowering medication, hypoglycaemic medication, inhalers, immunosuppressants.